ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102225 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102225; 2) Community: the network communities that were significantly associated with the response to NSC 102225; 3) Molecule: the relationships between components within communities and NSC 102225; 4) MDR: the compounds that were significantly associated with the NSC 102225.

NSC Compound Enrichment Correlation
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0286383688883668 0.27315843
NSC 237677 Null 0.0286383688883668 0.31703641
NSC 3053 Actinomycin D 0.0286383688883668 0.28814273
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0286383688883668 -0.066915145
NSC 339578 Null 0.0286383688883668 0.33753433
NSC 3424 Acridine, 9-(4-[bis(2-chloroethyl)amino]-1-methylbutylamino)-6-chloro-2-methoxy-, dihydrochloride 0.0286383688883668 0.5502613
NSC 357680 BUELLOLIDE 0.0286383688883668 0.41429762
NSC 362454 4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo- 0.0286383688883668 0.47437162
NSC 372950 Null 0.0286383688883668 0.28034853
NSC 381866 BAFILOMYCIN DERIV. 0.0286383688883668 0.3232927
Total:118  Current:83    [First] [Prev] [Next] [Last]